Details for New Drug Application (NDA): 206994
✉ Email this page to a colleague
The generic ingredient in LUBIPROSTONE is lubiprostone. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.
Summary for 206994
Tradename: | LUBIPROSTONE |
Applicant: | Dr Reddys |
Ingredient: | lubiprostone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 206994
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 8MCG | ||||
Approval Date: | Feb 8, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 24MCG | ||||
Approval Date: | Feb 8, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription